STTK Tests $6 Pivot Amid Strong Institutional Buying
$Shattuck Labs, Inc.(STTK)$
Shattuck Labs, Inc.(STTK) Soared +17.45%: Biotech Rocket Tests 52-Week High, $6 Pivot in Play
Latest Close Data:
STTK surged to $5.99 at the close on 2026-03-09, marking a +17.45% gain. The stock hit its 52-week high of $6.00 intraday, closing just a penny shy of that level.
Core Market Drivers:
-
The powerful rally appears to be driven by a combination of strong momentum and positive sentiment in the biotech sector.
-
The day saw significant net capital inflow, with large and small buy orders outpacing sells.
-
The low short volume ratio of 7.30% (as of 03-06) suggests limited immediate downside pressure from short sellers.
Technical Analysis:
-
The move was backed by massive volume (2.52M shares, Volume Ratio 2.63), confirming institutional interest.
-
The 6-day RSI at 92.03 signals extreme overbought conditions, a warning for a potential pullback.
-
However, the MACD (0.33) shows strong bullish momentum, with both DIF and DEA lines rising sharply, indicating the uptrend is intact.
Key Price Levels:
-
Immediate Pivot: $6.00 (52-Week High/Tested Resistance)
-
Primary Support: $4.15 (Recent Swing Low)
-
Strong Resistance: $6.00 (Psychological and Technical Barrier)
Valuation Perspective:
Valuation metrics reflect its clinical-stage status. The TTM P/E is -8.54, and the Forward P/E of -11.93 is significantly below its historical average of -2.64, indicating deep losses as it funds R&D. The P/S ratio is extremely high at 428.67, typical for pre-revenue biotechs.
Analyst Targets:
Sentiment is bullish among analysts. 5 firms cover STTK with an average price target of $9.40 (57% upside from the close). The consensus leans strongly Buy, with 1 Strong Buy and 4 Buy ratings vs. 2 Holds.
Weekly Outlook:
Expect high volatility and potential consolidation near the $6.00 pivot after the parabolic rise. A successful close above $6.00 could target the $6.50-$7.00 zone. Failure to hold gains may see a retest of support near $5.20-$5.50. The overbought RSI suggests a pause or pullback is likely in the short term.
Risk Disclaimer:
This analysis is for informational purposes only and not financial advice. Trading involves significant risk. Past performance does not guarantee future results. Please conduct your own research and consult a qualified financial advisor before making any investment decisions.
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
-
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
-
How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
